(Q50560920)

English

Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.

scientific article published on 5 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. (English)

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

0 references

author name string

Stephanie M Noe

1

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Mark A Green

2

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Harm HogenEsch

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Stanley L Hem

4

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

language of work or name

0 references

publication date

5 March 2010

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

28

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

20

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

3588-3594

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Prosthetic radioiodination of interleukin-8 ([(123/131)I]-IL-8): biological behavior in a mouse infection model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Iodotyrosine deiodinase from bovine thyroid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Distribution and pharmacokinetic analysis of angiostatin radioiodine labeled with high stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

t-Butyloxycarbonyl: an ordinary but promising group for protecting peptides from deiodination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Stability studies on fluorescein isothiocyanate--bovine serum albumin conjugate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Primary structure of bovine s1 casein. Complete sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

In vivo absorption of aluminium-containing vaccine adjuvants using 26Al.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Effect of pH on the Elution of Model Antigens from Aluminum-Containing Adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Neutrophils and immunity: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Mechanisms of adjuvancy: I--Metal oxides as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Mechanism of action of clinically approved adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Towards an understanding of the adjuvant action of aluminium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.085

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.02.085

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/20211692

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50560920&oldid=1368979185"